Search Results for ""

With EBP, clinicians at the point of care are in an ideal place to ask and answer clinically relevant questions. Seeing where improvements can be made is the start of the EBP process. This resource includes examples of questions that will help to identify issues or opportunities for improvement in your practice setting.

The drug reference sheets in ONS Voice are a quick guide to newly approved therapies or drugs with new indications. This resource from ONS clinical staff provides information through a nursing lens and includes the drug’s indication, side-effect profile, nursing considerations, patient education talking points, and more.

Explaining the complex biomarker testing process to your patients can be made simple by utilizing the Biomarker Testing in Non-Small Cell Lung Cancer Discussion Tool to guide this conversation with your patients. It provides patient friendly language to describe biomarker testing and the why, when, and how of the process. It also gives the patient space to write notes and capture their cancer’s biomarkers.

HealthMeasures is a resource to assist clinicians and researchers to expand and automate several patient-reported outcome measurement systems (PROMIS ®, NIH Toolbox ®, Neuro-QoL™, and ASCQ-Me ®). The website (https://www.healthmeasures.net/) provides easy searching to find the right tool along with information on application and scoring as well as many additional resources to help you incorporate these measures into your practice and research

Review this one-page reference sheet for tips on what to do before, during, and after an interview. This resource is provided by a collaboration between the Oncology Nursing Society and The James- The Ohio State University Comprehensive Cancer Center and Wexner Medical Center.

Review this one-page reference sheet for tips when preparing for a virtual interview. This resource is provided by a collaboration between the Oncology Nursing Society and The James-The Ohio State University Comprehensive Cancer Center and Wexner Medical Center.

Multiple myeloma (MM) is a common hematologic malignancy, and because of new treatments, survival rates for patients with this diagnosis are improving. Nurses are essential for patient care and education, especially with treatment advances for MM and the volume of novel therapies being approved. The downloadable resource found via the "Download PDF" button below provides a list of frequently asked questions about MM related to foundational knowledge, care coordination, and evidence-based practice, with straightforward talking points for reference.

Clinical practice resources support the integration of the latest evidence into practice and assist in the translation of this information to patients and families.

Utilize this tool to discuss hereditary cancer risk with a patient. It provides a list of hereditary risk red flags and helps in educating the patient on why they may need to be referred to a genetics professional.

Use this clinical practice resource to understand biomarker testing and the difference between germline and somatic variants.